Literature DB >> 18398672

Telomerase reconstitution contributes to resetting of circadian rhythm in fibroblasts.

Yi Qu1, Meng Mao, Xihong Li, Yanyou Liu, Jianmin Ding, Zhou Jiang, Chaomin Wan, Lin Zhang, Zhengrong Wang, Dezhi Mu.   

Abstract

The synchronization of the circadian signals to external or suprachiasmatic nucleus stimulation in the peripheral clocks is essential for maintaining the usual function of human body. However, aging will disrupt the synchronization of peripheral circadian rhythms, thus leading to some age-associated diseases. Up to now, little is known about the modification of the oscillatory rhythms in aged cells. A recent report showed that cell senescence in vascular human smooth muscle cells (HSMCs) altered circadian rhythms by a dysregulation of rhythmic gene expression. Furthermore, this alteration could be reversed by telomerase reconstitution. To test whether telomerase reconstitution can restore disrupted circadian rhythm in other types of senescent cells, we used fibroblasts as cell models to profoundly investigate the relationship between cell senescence and circadian rhythm modulation. We found that the response of rhythmic gene expression to serum stimulation was markedly attenuated in senescent fibroblasts, telomerase-reconstituted fibroblasts reset the circadian oscillation of rhythmic gene expression, and the activation of pERK-CREB and p38-CREB pathways might be involved in the circadian rhythm resetting. These findings suggested that telomerase reconstitution might be a good way to reset synchronization of peripheral circadian rhythms disrupted in senescent tissues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398672     DOI: 10.1007/s11010-008-9736-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  21 in total

1.  Involvement of the MAP kinase cascade in resetting of the mammalian circadian clock.

Authors:  M Akashi; E Nishida
Journal:  Genes Dev       Date:  2000-03-15       Impact factor: 11.361

Review 2.  Molecular genetics of circadian rhythms in mammals.

Authors:  D P King; J S Takahashi
Journal:  Annu Rev Neurosci       Date:  2000       Impact factor: 12.449

3.  Cellular senescence impairs circadian expression of clock genes in vitro and in vivo.

Authors:  Takeshige Kunieda; Tohru Minamino; Taro Katsuno; Kaoru Tateno; Jun-ichiro Nishi; Hideyuki Miyauchi; Masayuki Orimo; Sho Okada; Issei Komuro
Journal:  Circ Res       Date:  2006-01-19       Impact factor: 17.367

4.  Bimodal regulation of mPeriod promoters by CREB-dependent signaling and CLOCK/BMAL1 activity.

Authors:  Zdenka Travnickova-Bendova; Nicolas Cermakian; Steven M Reppert; Paolo Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 5.  Quo vadis basic and clinical chronobiology: promise for health maintenance.

Authors:  F Halberg
Journal:  Am J Anat       Date:  1983-12

6.  Circadian regulation of cAMP response element-mediated gene expression in the suprachiasmatic nuclei.

Authors:  K Obrietan; S Impey; D Smith; J Athos; D R Storm
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

Review 7.  The human circadian clock and aging.

Authors:  M A Hofman
Journal:  Chronobiol Int       Date:  2000-05       Impact factor: 2.877

Review 8.  Living by the clock: the circadian pacemaker in older people.

Authors:  Michel A Hofman; Dick F Swaab
Journal:  Ageing Res Rev       Date:  2005-08-25       Impact factor: 10.895

Review 9.  Aging human circadian rhythms: conventional wisdom may not always be right.

Authors:  Timothy H Monk
Journal:  J Biol Rhythms       Date:  2005-08       Impact factor: 3.182

10.  Beta-galactosidase activity as a biomarker of replicative senescence during the course of human fibroblast cultures.

Authors:  Andrea B Maier; Rudi G J Westendorp; Diana VAN Heemst
Journal:  Ann N Y Acad Sci       Date:  2007-04       Impact factor: 5.691

View more
  7 in total

Review 1.  Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment.

Authors:  Gabriele Sulli; Michael Tun Yin Lam; Satchidananda Panda
Journal:  Trends Cancer       Date:  2019-08-03

2.  Cardiac-specific mutation of Clock alters the quantitative measurements of physical activities without changing behavioral circadian rhythms.

Authors:  Michael L Ko; Liheng Shi; Ju-Yun Tsai; Martin E Young; Nichole Neuendorff; David J Earnest; Gladys Y-P Ko
Journal:  J Biol Rhythms       Date:  2011-10       Impact factor: 3.182

Review 3.  The Connection Between Cell Fate and Telomere.

Authors:  Ayse Basak Engin; Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Deregulation of the circadian clock constitutes a significant factor in tumorigenesis: a clockwork cancer. Part II. In vivo studies.

Authors:  Kristin Uth; Roger Sleigh
Journal:  Biotechnol Biotechnol Equip       Date:  2014-07-24       Impact factor: 1.632

Review 5.  Impact of the circadian clock on the aging process.

Authors:  Sara S Fonseca Costa; Jürgen A Ripperger
Journal:  Front Neurol       Date:  2015-03-06       Impact factor: 4.003

Review 6.  Broad targeting of angiogenesis for cancer prevention and therapy.

Authors:  Zongwei Wang; Charlotta Dabrosin; Xin Yin; Mark M Fuster; Alexandra Arreola; W Kimryn Rathmell; Daniele Generali; Ganji P Nagaraju; Bassel El-Rayes; Domenico Ribatti; Yi Charlie Chen; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Somaira Nowsheen; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Bill Helferich; Xujuan Yang; Gunjan Guha; Dipita Bhakta; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Dorota Halicka; Sulma I Mohammed; Asfar S Azmi; Alan Bilsland; W Nicol Keith; Lasse D Jensen
Journal:  Semin Cancer Biol       Date:  2015-01-16       Impact factor: 15.707

7.  BMAL1 associates with chromosome ends to control rhythms in TERRA and telomeric heterochromatin.

Authors:  Jinhee Park; Qiaoqiao Zhu; Emily Mirek; Li Na; Hamidah Raduwan; Tracy G Anthony; William J Belden
Journal:  PLoS One       Date:  2019-10-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.